Discovering a Common Goal,
Discovering a Cure


Research News
Drug News
Conference News
< Home

Biomarker Data from Genervon Trial Support Drug as Promising ALS Therapy
July 24, 2014
Pasadena, California-based Genervon Biopharmaceuticals,which recently completed a Phase IIa trial for their proprietary drug candidate GM604 in ALS, now announced the results of th...

U.S. Patent Granted to Amorfix for ALS Therapies Targeting Misfolded SOD1
July 24, 2014
Mutations in the gene encoding superoxide dismutase (SOD1) account for approximately 20% of familial ALS cases. The disease-causing mutations in SOD1 increase the protein’s prope...

Innovative Device Helps ALS Patients Speak with their Eyes
July 24, 2014
ALS patients suffer from progressive degeneration of motor neurons, which leads to muscle atrophy and loss of motor functions. However, in many cases, oculomotor neurons are preser...

Novartis Announces Trial on Presymptomatic AD Patients
July 24, 2014
Repeated failures in Phase III clinical trials for ALS and Alzheimer’s disease are driving researchers and drug developers to seek approaches to intervene earlier in the course o...

Kadimastem’s Stem Cell Therapy Holds Promise For Treating ALS
July 10, 2014
The Israeli biotechnology company Kadimastem has announced exciting results from their first preclinical study in ALS. The company’s proprietary technology is based on stem cell-...

The ALS Forum was developed by Prize4Life, Inc.
P.O. Box 425783 | Cambridge, MA 02142 | 617.500.7527
© 2014 Prize4Life, Inc.
Identified content provided through
a partnership with the Alzforum